NEW YORK–(BUSINESS WIRE)–lt;a href=”” target=”_blank”gt;$RMEDlt;/agt; lt;a href=”” target=”_blank”gt;#classactionlt;/agt;–The law firm of Kirby
McInerney LLP
is investigating potential claims against Ra Medical
Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED).
This investigation concerns whether Ra Medical has violated federal
securities laws and/or engaged in other unlawful business practices.

In September 2018, Ra Medical completed its initial public offering
(“IPO”), issuing approximately 4.5 million shares of common stock priced
at $17.00 per share. On March 14, 2019, the Company revealed that its
fourth quarter 2018 financial results had been negatively impacted by
issues related to the hiring and training of qualified sales personnel
and certain production limitations. On this news, Ra Medical’s stock
price fell $2.14 per share, approximately 32.6%, to close at $4.43 per
share on March 15, 2019. As of market close on May 28, 2019, the stock
price was $3.60.

If you acquired Ra Medical securities, have information, or would like
to learn more about these claims, please contact Thomas
W. Elrod
of Kirby McInerney LLP at 212-371-6600, by email at [email protected],
or by filling out this
contact form
, to discuss your rights or interests with respect to
these matters without any cost to you.

McInerney LLP
is a New York-based plaintiffs’ law firm concentrating
in securities, antitrust, and whistleblower litigation. The firm’s
efforts on behalf of shareholders in securities litigation have resulted
in recoveries totaling billions of dollars. Additional information about
the firm can be found at Kirby McInerney LLP’s website:

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.


Kirby McInerney LLP
Thomas W. Elrod, Esq., (212) 371-6600
[email protected]